Veterans, PTSD, and Ketamine: Research and Treatment Questions

Veterans seeking PTSD care deserve a clear account of ketamine research, including results that were not positive. The current VA/DoD guideline suggests against ketamine for PTSD. It recommends specific trauma-focused psychotherapies and supports certain medications, with decisions tailored to the individual.

Compounded ketamine is not FDA-approved. FDA has not reviewed compounded medications for safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric disorders. Compounded ketamine nasal spray is different from Spravato, the FDA-approved esketamine product used in certified healthcare settings.

What did the larger military study find?

A randomized 2022 study enrolled 158 veterans and active-duty service members with PTSD that had not adequately improved with prior antidepressant treatment. Participants received intravenous ketamine or placebo under research protocols. Ketamine did not show a significant advantage on the principal PTSD symptom measures, although the standard-dose group showed greater improvement on a depression measure.

That distinction matters. A depression result should not be described as a demonstrated PTSD benefit. Nor can a monitored infusion study establish what a compounded ketamine spray used at home will do. Other studies have reported different findings, but the guideline considers the overall evidence and harms.

Keep a full range of PTSD care in view

Ask about Cognitive Processing Therapy, Prolonged Exposure, and Eye Movement Desensitization and Reprocessing, as well as supported medication options. Discuss prior experiences, access barriers, and your preferences. If a previous treatment was difficult or incomplete, a clinician can help decide whether a different approach is warranted. For a medication-focused overview, read about the evidence for SSRIs and ketamine in PTSD.

Bring the rest of your health history into the conversation

Discuss sleep problems, pain, depression, substance use, head injuries, and all medications with your care team. These concerns may overlap, and each deserves assessment. Do not assume a single treatment will address every symptom. Coordinate changes with your existing VA or community clinicians when appropriate.

• Which condition is the proposed treatment intended to address?
• What evidence applies specifically to veterans with that condition?
• What monitoring or in-person assessment might I need?
• How will my current clinicians know about medication changes?
• What support is available if my symptoms worsen?

Avoid promises about eligibility or coverage

Military service alone does not establish eligibility for a particular prescription, and an article cannot confirm coverage for an individual plan. Ask the provider and your insurer or benefits team about referral requirements, authorization, and out-of-pocket costs before committing. You should also know how follow-up and urgent concerns will be handled.

Risks and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Other concerns include abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems. A prescription or lower dose does not eliminate these risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Virtual follow-up does not provide the same monitoring as an onsite team. Discuss whether the setting is appropriate, your medication interactions, and an emergency plan before treatment.

Discuss your questions with a clinician

Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. If treatment is prescribed, an independent, appropriately licensed compounding pharmacy dispenses the medication. A consultation does not guarantee a prescription; applicable prescribing and compounding requirements must be met.

Book a Free Virtual Appointment or Follow-Up to review your questions, alternatives, and next steps. This article provides general education and does not replace individualized medical advice.

Further reading: 2022 randomized veteran and service-member trial; VA/DoD: PTSD guideline; VA: trauma-focused psychotherapy; FDA: compounded-drug risks.